Table 3

‚ÄÉComparison of CFH SNP frequencies in MPGN II/DDD patients versus controls (allele frequencies given as f1 and f2)

SNPMPGNII/DDDControlsp
f1f2f1f2
Exon 2 I62V42 (G)2 (A)202 (G)60 (A)0.0051
IVS2 -18insTT42 (short)2 (long)194 (short)68 (long)0.0018
Exon 7 A307A16 (C)28 (A)88 (A)174 (C)0.72
Exon 9 Y402H28 (H)16 (Y)88 (H)174 (Y)0.00014
Exon 10 A473A40 (G)4 (A)74 (G)62 (A)0.000013
Exon 13 Q672Q35 (A)9 (G)217 (A)41 (G)0.45
Exon 18 D936E35 (D)9 (E)115 (D)19 (E)0.32